Fungal Infections In Marine Mammals: A 2025 Conservation Guide

Fungal infections, or mycotic diseases, pose an increasing challenge to marine mammal health, particularly in species like harbor porpoises, seals, and cetaceans. These opportunistic pathogens thrive in compromised hosts, leading to respiratory distress, neurological issues, and high mortality rates in both wild and captive populations.

Understanding the Rise of Mycotic Diseases

Marine mammals face a complex array of health threats from pollution, climate change, and nutritional stress, which weaken immune systems and allow fungi to establish infections. Primary fungal diseases are uncommon but have surged in recent years, with cases documented across the Pacific Northwest and North Sea regions. For instance, mucormycosis outbreaks have affected harbor porpoises and seals, highlighting a shift from terrestrial origins to marine environments.

These infections often start in the lungs and disseminate systemically, exploiting underlying conditions like parasitism or viral co-infections. Studies on stranded animals reveal that 2.4% of necropsied harbor porpoises along the Dutch coast suffered from confirmed mycotic lesions, underscoring the prevalence in free-ranging populations.

Key Fungal Pathogens Targeting Marine Species

Several fungi have adapted to infect marine mammals, with Aspergillus and Mucorales orders being predominant. Below is a breakdown of major culprits:

• Aspergillus species: Responsible for aspergillosis, primarily affecting the respiratory tract. In harbor porpoises, it causes granulomatous pneumonia with hyphae invading lung tissue.
• Mucorales fungi: Including Rhizomucor pusillus, Lichtheimia corymbifera, and Cunninghamella bertholletiae. These cause mucormycosis, noted in Pacific Northwest cetaceans and pinnipeds, with hyphae in brain, lungs, and kidneys.
• Mycobacterium species: Though bacterial-like, M. marinum and M. pinnipedii produce granulomatous lesions mimicking fungal pathology, often in skin and lungs.

Clinical Manifestations and Pathology

Symptoms vary by pathogen and organ involvement but commonly include lethargy, respiratory distress, and neurological deficits. In acute cases, animals exhibit emaciation, ascites, and enlarged lymph nodes. Histopathology reveals pyogranulomatous inflammation with intralesional hyphae, neutrophils, and macrophages surrounding necrotic centers.

Respiratory involvement dominates, seen in 67% of cases, with pneumonia featuring tertiary bronchial granulomas. Central nervous system (CNS) lesions occur in 33%, often from vascular spread, leading to encephalitis. Auditory system infections cause necropurulent otitis media, eroding tympanoperiotic bone and extending to the cerebellum.

In mucormycosis, affected animals show multisystemic parasitism, recent pregnancy, or herpesvirus co-infections as predisposing factors. Gross lesions include thoracic effusions and organ necrosis, confirming systemic spread.

Diagnosis Challenges in Wild and Captive Animals

Diagnosing mycotic infections requires necropsy for free-ranging strandings, involving histopathology, fungal culture, and PCR. Hyphae visualization in tissues is key, with immunohistochemistry aiding species identification. In live animals, bronchoalveolar lavage or biopsies detect pathogens early.

Captivity elevates risk due to stress and poor ventilation, increasing aspergillosis prevalence compared to wild counterparts. Differential diagnoses include bacterial pneumonia and mycobacteriosis, necessitating molecular tools for accuracy.

Treatment Approaches and Limitations

Treatment in rehabilitation settings targets antifungals like itraconazole or voriconazole for aspergillosis, combined with supportive care. However, disseminated cases have poor prognoses, with mortality high due to delayed intervention. Surgery for localized lesions is rarely feasible in large marine mammals.

Prevention focuses on habitat protection, reducing stressors like contaminants and noise, which predispose infections. Quarantine and air filtration in facilities mitigate outbreaks.

Epidemiology and Geographic Patterns

Mycotic diseases cluster in polluted inland waters, such as Washington, British Columbia, and the Dutch coast. Southern resident killer whales face elevated risks from prey scarcity and toxins. Stranding events post-2005 correlate with increased detections, suggesting environmental drivers.

Global reviews list over 40 fungal isolates from marine mammals, with Aspergillus most frequent. Emergence in the Pacific Northwest traces to land-based fungi adapting via runoff.

Impact on Conservation and Zoonotic Risks

These infections threaten endangered species, contributing to population declines. For killer whales, mucormycosis could exacerbate stressors. Human zoonoses are rare but include ‘seal finger’ from mycobacteria, resolving with antibiotics.

Conservation demands monitoring strandings, fungal surveillance, and ecosystem restoration to curb outbreaks.

FAQs

What causes fungal infections in marine mammals?

Weakened immunity from malnutrition, parasites, or pollution allows opportunistic fungi like Aspergillus to invade.

Are fungal diseases contagious between marine mammals?

No, they are opportunistic, not directly transmissible, but shared environments increase exposure.

How do we prevent mycotic outbreaks in captivity?

Use HEPA filters, maintain hygiene, and monitor health to reduce stress.

Can humans catch these fungi from marine mammals?

Rarely; localized skin infections possible, but systemic zoonoses are uncommon.

Why are cases rising in the Pacific Northwest?

Climate shifts and pollution likely spread terrestrial fungi to marine habitats.